These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27587472)

  • 1. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.
    Postmus I; Warren HR; Trompet S; Arsenault BJ; Avery CL; Bis JC; Chasman DI; de Keyser CE; Deshmukh HA; Evans DS; Feng Q; Li X; Smit RA; Smith AV; Sun F; Taylor KD; Arnold AM; Barnes MR; Barratt BJ; Betteridge J; Boekholdt SM; Boerwinkle E; Buckley BM; Chen YI; de Craen AJ; Cummings SR; Denny JC; Dubé MP; Durrington PN; Eiriksdottir G; Ford I; Guo X; Harris TB; Heckbert SR; Hofman A; Hovingh GK; Kastelein JJ; Launer LJ; Liu CT; Liu Y; Lumley T; McKeigue PM; Munroe PB; Neil A; Nickerson DA; Nyberg F; O'Brien E; O'Donnell CJ; Post W; Poulter N; Vasan RS; Rice K; Rich SS; Rivadeneira F; Sattar N; Sever P; Shaw-Hawkins S; Shields DC; Slagboom PE; Smith NL; Smith JD; Sotoodehnia N; Stanton A; Stott DJ; Stricker BH; Stürmer T; Uitterlinden AG; Wei WQ; Westendorp RG; Whitsel EA; Wiggins KL; Wilke RA; Ballantyne CM; Colhoun HM; Cupples LA; Franco OH; Gudnason V; Hitman G; Palmer CN; Psaty BM; Ridker PM; Stafford JM; Stein CM; Tardif JC; Caulfield MJ; Jukema JW; Rotter JI; Krauss RM
    J Med Genet; 2016 Dec; 53(12):835-845. PubMed ID: 27587472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
    Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
    DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesteryl ester transfer protein polymorphisms, statin use, and their impact on cholesterol levels and cardiovascular events.
    Leusink M; Onland-Moret NC; Asselbergs FW; Ding B; Kotti S; van Zuydam NR; Papp AC; Danchin N; Donnelly L; Morris AD; Chasman DI; Doevendans PA; Klungel OH; Ridker PM; van Gilst WH; Simon T; Nyberg F; Palmer CN; Sadee W; van der Harst P; de Bakker PI; de Boer A; Verstuyft C; Maitland-van der Zee AH
    Clin Pharmacol Ther; 2014 Mar; 95(3):314-20. PubMed ID: 24080640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.
    Blankenberg S; Rupprecht HJ; Bickel C; Jiang XC; Poirier O; Lackner KJ; Meyer J; Cambien F; Tiret L;
    J Am Coll Cardiol; 2003 Jun; 41(11):1983-9. PubMed ID: 12798569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
    Nicholls SJ; Brewer HB; Kastelein JJ; Krueger KA; Wang MD; Shao M; Hu B; McErlean E; Nissen SE
    JAMA; 2011 Nov; 306(19):2099-109. PubMed ID: 22089718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.
    Ference BA; Kastelein JJP; Ginsberg HN; Chapman MJ; Nicholls SJ; Ray KK; Packard CJ; Laufs U; Brook RD; Oliver-Williams C; Butterworth AS; Danesh J; Smith GD; Catapano AL; Sabatine MS
    JAMA; 2017 Sep; 318(10):947-956. PubMed ID: 28846118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of Lipid-Lowering Agents: an Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies.
    Messas N; Dubé MP; Tardif JC
    Curr Atheroscler Rep; 2017 Sep; 19(11):43. PubMed ID: 28944433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.
    Schierer A; Been LF; Ralhan S; Wander GS; Aston CE; Sanghera DK
    Pharmacogenet Genomics; 2012 Feb; 22(2):95-104. PubMed ID: 22143414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry.
    Ahmad T; Chasman DI; Buring JE; Lee IM; Ridker PM; Everett BM
    Circ Cardiovasc Genet; 2011 Feb; 4(1):74-80. PubMed ID: 21252145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study.
    Ridker PM; Paré G; Parker AN; Zee RY; Miletich JP; Chasman DI
    Circ Cardiovasc Genet; 2009 Feb; 2(1):26-33. PubMed ID: 20031564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.
    Wei WQ; Li X; Feng Q; Kubo M; Kullo IJ; Peissig PL; Karlson EW; Jarvik GP; Lee MTM; Shang N; Larson EA; Edwards T; Shaffer CM; Mosley JD; Maeda S; Horikoshi M; Ritchie M; Williams MS; Larson EB; Crosslin DR; Bland HT; Pacheco JA; Rasmussen-Torvik LJ; Cronkite D; Hripcsak G; Cox NJ; Wilke RA; Stein CM; Rotter JI; Momozawa Y; Roden DM; Krauss RM; Denny JC
    Circulation; 2018 Oct; 138(17):1839-1849. PubMed ID: 29703846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
    Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.
    Millwood IY; Bennett DA; Holmes MV; Boxall R; Guo Y; Bian Z; Yang L; Sansome S; Chen Y; Du H; Yu C; Hacker A; Reilly DF; Tan Y; Hill MR; Chen J; Peto R; Shen H; Collins R; Clarke R; Li L; Walters RG; Chen Z;
    JAMA Cardiol; 2018 Jan; 3(1):34-43. PubMed ID: 29141072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis.
    Pott J; Kheirkhah A; Gadin JR; Kleber ME; Delgado GE; Kirsten H; Forer L; Hauck SM; Burkhardt R; Scharnagl H; Loeffler M; März W; Thiery J; Gieger C; Peters A; Silveira A; Hooft FV; Kronenberg F; Scholz M
    Biol Sex Differ; 2024 Mar; 15(1):26. PubMed ID: 38532495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian randomization study of lipid metabolism characteristics and migraine risk.
    Hong P; Han L; Wan Y
    Eur J Pain; 2024 Jul; 28(6):978-986. PubMed ID: 38183343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.
    Feng Q; Wei WQ; Chung CP; Levinson RT; Bastarache L; Denny JC; Stein CM
    Pharmacogenomics J; 2017 Mar; 17(2):204-208. PubMed ID: 26902539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.
    Postmus I; Trompet S; Deshmukh HA; Barnes MR; Li X; Warren HR; Chasman DI; Zhou K; Arsenault BJ; Donnelly LA; Wiggins KL; Avery CL; Griffin P; Feng Q; Taylor KD; Li G; Evans DS; Smith AV; de Keyser CE; Johnson AD; de Craen AJ; Stott DJ; Buckley BM; Ford I; Westendorp RG; Slagboom PE; Sattar N; Munroe PB; Sever P; Poulter N; Stanton A; Shields DC; O'Brien E; Shaw-Hawkins S; Chen YD; Nickerson DA; Smith JD; Dubé MP; Boekholdt SM; Hovingh GK; Kastelein JJ; McKeigue PM; Betteridge J; Neil A; Durrington PN; Doney A; Carr F; Morris A; McCarthy MI; Groop L; Ahlqvist E; ; Bis JC; Rice K; Smith NL; Lumley T; Whitsel EA; Stürmer T; Boerwinkle E; Ngwa JS; O'Donnell CJ; Vasan RS; Wei WQ; Wilke RA; Liu CT; Sun F; Guo X; Heckbert SR; Post W; Sotoodehnia N; Arnold AM; Stafford JM; Ding J; Herrington DM; Kritchevsky SB; Eiriksdottir G; Launer LJ; Harris TB; Chu AY; Giulianini F; MacFadyen JG; Barratt BJ; Nyberg F; Stricker BH; Uitterlinden AG; Hofman A; Rivadeneira F; Emilsson V; Franco OH; Ridker PM; Gudnason V; Liu Y; Denny JC; Ballantyne CM; Rotter JI; Adrienne Cupples L; Psaty BM; Palmer CN; Tardif JC; Colhoun HM; Hitman G; Krauss RM; Wouter Jukema J; Caulfield MJ
    Nat Commun; 2014 Oct; 5():5068. PubMed ID: 25350695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis.
    Hourcade-Potelleret F; Laporte S; Lehnert V; Delmar P; Benghozi R; Torriani U; Koch R; Mismetti P
    Heart; 2015 Jun; 101(11):847-53. PubMed ID: 25872524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of common SNPs and haplotypes in CETP gene with HDL cholesterol levels in Latvian population.
    Radovica I; Fridmanis D; Vaivade I; Nikitina-Zake L; Klovins J
    PLoS One; 2013; 8(5):e64191. PubMed ID: 23675527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.